FilingSEC EDGAR8-K
Actuate Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notice
· SEC accepted
StageNotice Received
Filing content
Actuate Therapeutics received a Nasdaq deficiency notice for failing to maintain the $1.00 minimum bid price requirement, with a compliance deadline of April 26, 2027.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…